Skip to main content

Table 1 Patient characteristics during the study period (N = 417). Cochran-Armitage test for trend

From: Clinical and echocardiographic trends in percutaneous balloon mitral valvuloplasty

Patient characteristics 1990–1999
(N = 165)
2000–2009
(N = 182)
2010–2019
(N = 70)
P-value
(test trend)
Age-adjusted
Age (Mean ± SD years)
(Median; range)
57.7 ± 10.8
(57; 28–84)
55.3 ± 11.0
(56; 23–88)
55.1 ± 11.3
(54; 29–80)
.09
Sex (female) 139 (84.2) 147 (80.8) 48 (69.6) .02 .02
Obesity (BMI > 30) 79 (48.2) 71 (39.2) 29 (41.4) .19 .27
Smoking 48 (29.8) 68 (37.8) 37 (52.9) .001 .001
Hypertension 66 (40.5) 81 (45.3) 38 (54.3) .06 .02
Dyslipidemia 69 (42.1) 80 (45.2) 40 (58.0) .04 .02
Diabetes mellitus 44 (27.0) 43 (24.2) 22 (31.1) .64 .11
Chronic kidney failure 22 (13.6) 26 (14.7) 24 (34.8) .001 .001
Ischemic heart disease 45 (27.6) 49 (27.7) 28 (40.6) .10 .01
CABG 7 (4.3) 10 (5.6) 6 (9.0) .19 .20
Atrial fibrillation 79 (48.2) 92 (50.5) 40 (57.1) .24 .63
Stroke 21 (13.0) 26 (14.4) 10 (14.7) .68 .74
Endocarditis 6 (3.8) 3 (1.7) 1 (1.5) .21 .27
  1. CABG coronary artery bypass graft